Search Results for citation:"89 FR 104209"

Found 2 results
Skip to main content

Search Results: citation:"89 FR 104209"

  • Type:Notice
    Citation:89 FR 104209
    Reading Time:about a minute or two

    The Subcutaneous Drug Development & Delivery Consortium, Inc. has notified the Attorney General and the Federal Trade Commission about changes in its membership as required by law. New members of this research venture include Janssen Research & Development, LLC, Novo Nordisk from Denmark, and Ypsomed AG from Switzerland. This action is part of the ongoing compliance with the National Cooperative Research and Production Act, which limits the damages that antitrust plaintiffs can recover in certain circumstances. The Consortium plans to keep the membership open and continues to update the authorities on its developments.

    Simple Explanation

    The Subcutaneous Drug Development & Delivery Consortium has added three new members to its team and told the government about it, just like they are supposed to do, to keep everything fair and honest.

  • Type:Notice
    Citation:89 FR 104209
    Reading Time:about a minute or two

    The UHD Alliance, Inc. has filed notifications with the Attorney General and the Federal Trade Commission to disclose a change in its membership, specifically adding TTE Corporation from Shenzhen, China, as a new member. This filing is made under the National Cooperative Research and Production Act of 1993 to limit antitrust damages under certain conditions. The UHD Alliance stated that no other membership or activity changes have been made, and they plan to continue filing updates. The Department of Justice has published previous notices related to these notifications in the Federal Register.

    Simple Explanation

    The UHD Alliance added a new friend, TTE Corporation, to their group, and they told the grown-ups in charge (like the police for businesses) to make sure everything is fair and okay.